Daniel Young
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel Young has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Antoine Dufour
Departments of Physiology and Pharmacology & Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, Canada
3 shared publications - Afshin Derakhshani
Cumming School of Medicine, University of Calgary 3 Calvin, Phoebe, and Joan Snyder Institute for Chronic Diseases Calgary
1 shared publication - Bayan Abou Mehrem
Cumming School of Medicine, University of Calgary 3 Calvin, Phoebe, and Joan Snyder Institute for Chronic Diseases Calgary
1 shared publication - Bryan George Yipp
Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases, Department of Critical Care, Cumming School of Medicine, University of Calgary, Calgary, Canada
1 shared publication - Claudia V. Jakubzick
The Geisel School of Medicine at Dartmouth 10 Department of Microbiology and Immunology Lebanon, NH
1 shared publication - Edward Jenkins
Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK
1 shared publication
Latest Publications
- 22 July 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (8)
A nerve and mast cell sentinel system releases extracellular condensates to induce macrophage repair
There is a higher density of immune cells in peritoneal fluid than is found in blood. Thus, any perturbations, from sterile injury to endometriosis to ovarian cancer, require immune cells to recognize and nucleate to these sites. Using peritoneal injuries as a prototype, we saw a massive recruitment of large peritoneal macrophages (LPMs) interspersed with mast cells. The mast cells were activated by sensory neurons to mobilize their 1-μm granules to the cell surface. Lattice light sheet microscopy unveiled a new step in the mast cell degranulation. After granules fused with the plasma membrane, cytonemes (very thin long filopodia) grabbed the granules from the mast cell surface and deposited them on neighboring LPMs. The granules were membraneless biomolecular condensates and harbored more than 200 different proteins, including MARCO, which mediated rapid LPM aggregation to the injury nidus. The condensates also induced a repair-like phenotype in the macrophages that helped heal the injury site.
- 22 July 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (8)
A nerve and mast cell sentinel system releases extracellular condensates to induce macrophage repair
There is a higher density of immune cells in peritoneal fluid than is found in blood. Thus, any perturbations, from sterile injury to endometriosis to ovarian cancer, require immune cells to recognize and nucleate to these sites. Using peritoneal injuries as a prototype, we saw a massive recruitment of large peritoneal macrophages (LPMs) interspersed with mast cells. The mast cells were activated by sensory neurons to mobilize their 1-μm granules to the cell surface. Lattice light sheet microscopy unveiled a new step in the mast cell degranulation. After granules fused with the plasma membrane, cytonemes (very thin long filopodia) grabbed the granules from the mast cell surface and deposited them on neighboring LPMs. The granules were membraneless biomolecular condensates and harbored more than 200 different proteins, including MARCO, which mediated rapid LPM aggregation to the injury nidus. The condensates also induced a repair-like phenotype in the macrophages that helped heal the injury site.
- Open Access
Multi omics reveals mesodermal fate bias and enables predictive cell state control in human pluripotent stem cell biomanufacturing
Despite accelerating interest in using human induced pluripotent stem cell (hiPSC)–derived products for disease modeling and therapeutic development, there is substantial evidence that conventional culture approaches do not fully recapitulate natural embryonic nor lineage-committed states. It remains poorly understood how in vitro environmental conditions cause divergence from natural developmental trajectories, and current strategies emphasize restricted characterization of phenotype without appreciating the complexity of biology in maintaining pluripotency and driving differentiation. To address this knowledge gap, we examined hiPSC cell state during short-term culture in stirred-suspension bioprocesses under varying oxygen and agitation conditions. We profiled intracellular metabolic, transcriptional, and proteomic changes to characterize cellular responses to engineered environments and implications for cell phenotype. Using a random forest framework, we modeled population dynamics over time across metabolic and transcriptional programs and mapped those predictions onto hallmark biological signatures. This integrative approach captures and identifies environmentally reinforced programs, offering a framework to guide optimization of pluripotent cell state maintenance and differentiation.
Open AccessMulti omics reveals mesodermal fate bias and enables predictive cell state control in human pluripotent stem cell biomanufacturing
Despite accelerating interest in using human induced pluripotent stem cell (hiPSC)–derived products for disease modeling and therapeutic development, there is substantial evidence that conventional culture approaches do not fully recapitulate natural embryonic nor lineage-committed states. It remains poorly understood how in vitro environmental conditions cause divergence from natural developmental trajectories, and current strategies emphasize restricted characterization of phenotype without appreciating the complexity of biology in maintaining pluripotency and driving differentiation. To address this knowledge gap, we examined hiPSC cell state during short-term culture in stirred-suspension bioprocesses under varying oxygen and agitation conditions. We profiled intracellular metabolic, transcriptional, and proteomic changes to characterize cellular responses to engineered environments and implications for cell phenotype. Using a random forest framework, we modeled population dynamics over time across metabolic and transcriptional programs and mapped those predictions onto hallmark biological signatures. This integrative approach captures and identifies environmentally reinforced programs, offering a framework to guide optimization of pluripotent cell state maintenance and differentiation.
- Open Access
- 14 May 2021
- Published by Wiley in The FASEB Journal
- Vol. 35 (S1)
Proteomic Analysis Suggests Altered Mitochondrial Metabolic Profile in Diabetic Cardiomyopathy
Diabetic cardiomyopathy (DCM) occurs independently of coronary artery disease or hypertension, often leading to heart failure and death. Although remarkable progress has been made in recent years, there is still no specific therapy for myocardial damage induced by DCM, mainly due to its unclear molecular basis. To elucidate the molecular mechanisms involved in the DCM progress, we have performed advanced proteomic profiling analysis of heart tissue samples from the membrane‐bound leptin receptor deficient ( db/db ) mice, a widely used murine model of type 2 diabetes. As previously shown by our research group, db/db mice exhibit clinically relevant DCM phenotype by 6 months of age that includes diastolic dysfunction, cardiac hypertrophy, and cardiac fibrosis. Six‐month‐old C57BL/6J‐lepr/lepr ( db/db ) and C57BL/6J (wild type [WT]) male mice were euthanized, and the left ventricle (LV) was appropriately collected and processed for proteomic analysis. By shotgun proteomics performed after dimethyl labelling, we identified 77 differentially expressed proteins in LV of db/db mice. Among these, 27 proteins were downregulated in response to chronic diabetes, while 50 were upregulated. Many of these proteins were associated with energy metabolism, cytoskeleton organization, and calcium handling. The peptide levels of subunits alpha, beta and delta of ATP synthase were upregulated in the LVs of db/db mice. These subunits are arranged to form the F1 domain, a catalytic assembly of the enzyme. We also found a marked induction of cytochrome c1 in db/db mice, which is a catalytic core subunit of the complex III, responsible for electron transfer to cytochrome c. We propose that this may represent an adaptive mechanism by which the diabetic heart attempts to increase electron transfer and thereby enhance mitochondrial ATP production. Conversely, in db/db mice we found a decrease in peptide levels of NADH dehydrogenase 1 beta subcomplex subunit 11, a subunit of complex I that catalyzes transfer of electrons to ubiquinone. In diabetic hearts, we also found a downregulation of atypical kinase COQ8A, an essential lipid‐soluble electron transporter involved in the biosynthesis of ubiquinone. These data suggest that despite attempts by hearts from the diabetic mice to augment mitochondrial ATP production, decreased levels of key components of the electron transport chain may contribute to impaired mitochondrial ATP production. It is likely that ATP synthase subunits and cytochrome c1 may also be downregulated with prolonged persistence of the diabetic phenotype. Our study suggests that diabetic hearts displayed altered expression of mitochondrial metabolic peptides, which may contribute to the progression of DCM in db/db mice.
- 14 May 2021
- Published by Wiley in The FASEB Journal
- Vol. 35 (S1)
Open AccessProteomic Analysis Suggests Altered Mitochondrial Metabolic Profile in Diabetic Cardiomyopathy
Diabetic cardiomyopathy (DCM) occurs independently of coronary artery disease or hypertension, often leading to heart failure and death. Although remarkable progress has been made in recent years, there is still no specific therapy for myocardial damage induced by DCM, mainly due to its unclear molecular basis. To elucidate the molecular mechanisms involved in the DCM progress, we have performed advanced proteomic profiling analysis of heart tissue samples from the membrane‐bound leptin receptor deficient ( db/db ) mice, a widely used murine model of type 2 diabetes. As previously shown by our research group, db/db mice exhibit clinically relevant DCM phenotype by 6 months of age that includes diastolic dysfunction, cardiac hypertrophy, and cardiac fibrosis. Six‐month‐old C57BL/6J‐lepr/lepr ( db/db ) and C57BL/6J (wild type [WT]) male mice were euthanized, and the left ventricle (LV) was appropriately collected and processed for proteomic analysis. By shotgun proteomics performed after dimethyl labelling, we identified 77 differentially expressed proteins in LV of db/db mice. Among these, 27 proteins were downregulated in response to chronic diabetes, while 50 were upregulated. Many of these proteins were associated with energy metabolism, cytoskeleton organization, and calcium handling. The peptide levels of subunits alpha, beta and delta of ATP synthase were upregulated in the LVs of db/db mice. These subunits are arranged to form the F1 domain, a catalytic assembly of the enzyme. We also found a marked induction of cytochrome c1 in db/db mice, which is a catalytic core subunit of the complex III, responsible for electron transfer to cytochrome c. We propose that this may represent an adaptive mechanism by which the diabetic heart attempts to increase electron transfer and thereby enhance mitochondrial ATP production. Conversely, in db/db mice we found a decrease in peptide levels of NADH dehydrogenase 1 beta subcomplex subunit 11, a subunit of complex I that catalyzes transfer of electrons to ubiquinone. In diabetic hearts, we also found a downregulation of atypical kinase COQ8A, an essential lipid‐soluble electron transporter involved in the biosynthesis of ubiquinone. These data suggest that despite attempts by hearts from the diabetic mice to augment mitochondrial ATP production, decreased levels of key components of the electron transport chain may contribute to impaired mitochondrial ATP production. It is likely that ATP synthase subunits and cytochrome c1 may also be downregulated with prolonged persistence of the diabetic phenotype. Our study suggests that diabetic hearts displayed altered expression of mitochondrial metabolic peptides, which may contribute to the progression of DCM in db/db mice.
- Open Access
- 1 July 1996
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 11 (4) , 395-399
Cytogenetic effects of caffeine during in vivo mouse oocyte maturation
Numerous investigators have studied the reproductive and genetic toxicity of caffeine. Caffeine has also been reported to retard meiotic progression and induce aneuploidy in hamster oocytes in vitro. However, the ability of caffeine to induce aneuploidy in mammalian oocytes in vivo has not been reported. The objective of this study was to test the hypothesis that chemcal-mduced pelturbations during in vivo oocyte meiotic maturation (OM) predispose oocytes to chromosome missegregation. Caffeine inhibits cAMP phosphodiesterase, which is needed for dephosphorylating p34cdc2 kinase and initiating OM. Following superovulation, a dose of 150 mg/kg caffeine was administered to Institute of Cancer Research (ICR) female mice at various times prior to metaphase I (MI). Ovulated oocytes were collected from the oviducts and processed for cytogenetic analysis. Statistical analyses of the frequencies of hyperploid, MI, diploid, premature centromere separation and single chromatids revealed nonsignificant (P > 0.05) differences between the controls and each of the caffeine groups. Structural chromosome aberrations were not found. Under our experimental conditions, we rejected the hypothesis and concluded that caffeine neither retarded the rate of OM nor increased the incidence of aneuploidy in mouse oocytes. The factors responsible for the different in vivo and in vitro responses require investigation.
- 1 July 1996
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 11 (4) , 395-399
Open AccessCytogenetic effects of caffeine during in vivo mouse oocyte maturation
Numerous investigators have studied the reproductive and genetic toxicity of caffeine. Caffeine has also been reported to retard meiotic progression and induce aneuploidy in hamster oocytes in vitro. However, the ability of caffeine to induce aneuploidy in mammalian oocytes in vivo has not been reported. The objective of this study was to test the hypothesis that chemcal-mduced pelturbations during in vivo oocyte meiotic maturation (OM) predispose oocytes to chromosome missegregation. Caffeine inhibits cAMP phosphodiesterase, which is needed for dephosphorylating p34cdc2 kinase and initiating OM. Following superovulation, a dose of 150 mg/kg caffeine was administered to Institute of Cancer Research (ICR) female mice at various times prior to metaphase I (MI). Ovulated oocytes were collected from the oviducts and processed for cytogenetic analysis. Statistical analyses of the frequencies of hyperploid, MI, diploid, premature centromere separation and single chromatids revealed nonsignificant (P > 0.05) differences between the controls and each of the caffeine groups. Structural chromosome aberrations were not found. Under our experimental conditions, we rejected the hypothesis and concluded that caffeine neither retarded the rate of OM nor increased the incidence of aneuploidy in mouse oocytes. The factors responsible for the different in vivo and in vitro responses require investigation.